List of Tables
Table 1. Chronic Metabolic Disease Drug Market Trends
Table 2. Chronic Metabolic Disease Drug Market Drivers & Opportunity
Table 3. Chronic Metabolic Disease Drug Market Challenges
Table 4. Chronic Metabolic Disease Drug Market Restraints
Table 5. Global Chronic Metabolic Disease Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Chronic Metabolic Disease Drug Revenue Market Share by Company (2019-2024)
Table 7. Global Chronic Metabolic Disease Drug Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Chronic Metabolic Disease Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Chronic Metabolic Disease Drug Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Chronic Metabolic Disease Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Chronic Metabolic Disease Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Chronic Metabolic Disease Drug
Table 13. Global Chronic Metabolic Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Metabolic Disease Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Metabolic Disease Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Chronic Metabolic Disease Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Chronic Metabolic Disease Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Chronic Metabolic Disease Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Chronic Metabolic Disease Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Chronic Metabolic Disease Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Chronic Metabolic Disease Drug Sales Volume by Type (2019-2024) & (Tons)
Table 23. Global Chronic Metabolic Disease Drug Sales Volume by Type (2025-2030) & (Tons)
Table 24. Global Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Chronic Metabolic Disease Drug Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Chronic Metabolic Disease Drug Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Chronic Metabolic Disease Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Chronic Metabolic Disease Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Chronic Metabolic Disease Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Chronic Metabolic Disease Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Chronic Metabolic Disease Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Chronic Metabolic Disease Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Chronic Metabolic Disease Drug Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Chronic Metabolic Disease Drug Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Chronic Metabolic Disease Drug Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Chronic Metabolic Disease Drug Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Chronic Metabolic Disease Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Chronic Metabolic Disease Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Chronic Metabolic Disease Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Chronic Metabolic Disease Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global Chronic Metabolic Disease Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global Chronic Metabolic Disease Drug Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Chronic Metabolic Disease Drug Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Chronic Metabolic Disease Drug Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Chronic Metabolic Disease Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global Chronic Metabolic Disease Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global Chronic Metabolic Disease Drug Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Chronic Metabolic Disease Drug Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Chronic Metabolic Disease Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Chronic Metabolic Disease Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Chronic Metabolic Disease Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Chronic Metabolic Disease Drug Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Chronic Metabolic Disease Drug Sales Volume, (2025-2030) & (Tons)
Table 57. Novartis Company Information
Table 58. Novartis Introduction and Business Overview
Table 59. Novartis Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. Novartis Chronic Metabolic Disease Drug Product Offerings
Table 61. Novartis Recent Development
Table 62. Daiichi Sankyo Company Information
Table 63. Daiichi Sankyo Introduction and Business Overview
Table 64. Daiichi Sankyo Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. Daiichi Sankyo Chronic Metabolic Disease Drug Product Offerings
Table 66. Daiichi Sankyo Recent Development
Table 67. Actelion Pharmaceuticals Company Information
Table 68. Actelion Pharmaceuticals Introduction and Business Overview
Table 69. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Product Offerings
Table 71. Actelion Pharmaceuticals Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Introduction and Business Overview
Table 74. Boehringer Ingelheim Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Chronic Metabolic Disease Drug Product Offerings
Table 76. Boehringer Ingelheim Recent Development
Table 77. Eli Lilly Company Information
Table 78. Eli Lilly Introduction and Business Overview
Table 79. Eli Lilly Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Eli Lilly Chronic Metabolic Disease Drug Product Offerings
Table 81. Eli Lilly Recent Development
Table 82. Fresenius Kabi Company Information
Table 83. Fresenius Kabi Introduction and Business Overview
Table 84. Fresenius Kabi Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Fresenius Kabi Chronic Metabolic Disease Drug Product Offerings
Table 86. Fresenius Kabi Recent Development
Table 87. Torrent Labs Company Information
Table 88. Torrent Labs Introduction and Business Overview
Table 89. Torrent Labs Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Torrent Labs Chronic Metabolic Disease Drug Product Offerings
Table 91. Torrent Labs Recent Development
Table 92. Pfizer Company Information
Table 93. Pfizer Introduction and Business Overview
Table 94. Pfizer Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Pfizer Chronic Metabolic Disease Drug Product Offerings
Table 96. Pfizer Recent Development
Table 97. Novo Nordisk Company Information
Table 98. Novo Nordisk Introduction and Business Overview
Table 99. Novo Nordisk Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Novo Nordisk Chronic Metabolic Disease Drug Product Offerings
Table 101. Novo Nordisk Recent Development
Table 102. AstraZeneca plc Company Information
Table 103. AstraZeneca plc Introduction and Business Overview
Table 104. AstraZeneca plc Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. AstraZeneca plc Chronic Metabolic Disease Drug Product Offerings
Table 106. AstraZeneca plc Recent Development
Table 107. Regeneron Pharmaceuticals Company Information
Table 108. Regeneron Pharmaceuticals Introduction and Business Overview
Table 109. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Product Offerings
Table 111. Regeneron Pharmaceuticals Recent Development
Table 112. GlaxoSmithKline plc Company Information
Table 113. GlaxoSmithKline plc Introduction and Business Overview
Table 114. GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. GlaxoSmithKline plc Chronic Metabolic Disease Drug Product Offerings
Table 116. GlaxoSmithKline plc Recent Development
Table 117. Merck & Co. Inc Company Information
Table 118. Merck & Co. Inc Introduction and Business Overview
Table 119. Merck & Co. Inc Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. Merck & Co. Inc Chronic Metabolic Disease Drug Product Offerings
Table 121. Merck & Co. Inc Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Chronic Metabolic Disease Drug Downstream Customers
Table 125. Chronic Metabolic Disease Drug Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Metabolic Disease Drug Product Picture
Figure 2. Global Chronic Metabolic Disease Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Chronic Metabolic Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Chronic Metabolic Disease Drug Sales Volume (2019-2030) & (Tons)
Figure 5. Global Chronic Metabolic Disease Drug Sales Price (2019-2030) & (US$/Ton)
Figure 6. Chronic Metabolic Disease Drug Report Years Considered
Figure 7. Global Chronic Metabolic Disease Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Chronic Metabolic Disease Drug Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Metabolic Disease Drug Revenue in 2023
Figure 10. Chronic Metabolic Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Hypertension Drug Picture
Figure 12. Hyperlipidemia Drug Picture
Figure 13. High Blood Sugar Drug Picture
Figure 14. High Uric Acid Drug Picture
Figure 15. Global Chronic Metabolic Disease Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Chronic Metabolic Disease Drug Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Chronic Metabolic Disease Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 18. Global Chronic Metabolic Disease Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Chronic Metabolic Disease Drug Price by Type (2019-2030) & (US$/Ton)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Clinic
Figure 22. Product Picture of Others
Figure 23. Global Chronic Metabolic Disease Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Chronic Metabolic Disease Drug Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Chronic Metabolic Disease Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 26. Global Chronic Metabolic Disease Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Chronic Metabolic Disease Drug Price by Application (2019-2030) & (US$/Ton)
Figure 28. North America Chronic Metabolic Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Chronic Metabolic Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Chronic Metabolic Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Chronic Metabolic Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Chronic Metabolic Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Chronic Metabolic Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Chronic Metabolic Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Chronic Metabolic Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Chronic Metabolic Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Chronic Metabolic Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Chronic Metabolic Disease Drug Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Chronic Metabolic Disease Drug Sales Volume (%), (2019-2030)
Figure 40. United States Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. China Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. China Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 58. India Chronic Metabolic Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Chronic Metabolic Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 60. India Chronic Metabolic Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 61. Chronic Metabolic Disease Drug Industrial Chain
Figure 62. Chronic Metabolic Disease Drug Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
